Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2005
09/13/2005CA2371587C Piperidine derivatives useful as ccr5 antagonists
09/13/2005CA2371583C Piperazine derivatives useful as ccr5 antagonists
09/13/2005CA2358724C New cyclobutene-dione derivatives, their method of preparation and pharmaceutical compositions containing them
09/13/2005CA2317462C 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
09/13/2005CA2292927C New imidazolin compounds, the process for preparing them and the pharmaceutical compositions that contain them
09/13/2005CA2231105C Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
09/13/2005CA2216099C Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/13/2005CA2181901C Pyridazinone derivatives
09/13/2005CA2179634C 4-arylisoindole analgesics
09/13/2005CA2078700C Imidazolylmethyl-pyridines
09/09/2005WO2005082895A1 Novel carboxamides for use as xa inhibitors
09/09/2005WO2005082892A2 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
09/09/2005WO2005082891A1 -quinolinecarbonitrile protein kinase inhibitors
09/09/2005WO2005082890A1 Novel compounds
09/09/2005WO2005082889A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005WO2005082888A1 Process for the preparation of magnesium salt of omeprazole
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082886A1 Piperidine derivatives
09/09/2005WO2005082885A1 Imidazole based kinase inhibitors
09/09/2005WO2005082884A2 2-pyridin-2yl-pyrimidine derivatives useful in the treatment of gastro-esophagea l reflux disease
09/09/2005WO2005082883A2 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
09/09/2005WO2005082867A1 Novel 1,2,4-benzotriazine-1,4-dioxides
09/09/2005WO2005082866A2 Substituted 1, 2, 4- triazole derivatives as oxytocin antagonists
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082864A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
09/09/2005WO2005082863A2 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
09/09/2005WO2005082862A2 Benzimidazolyl derivatives as kinase inhibitors
09/09/2005WO2005082859A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
09/09/2005WO2005082858A2 Isoquinoline derivatives
09/09/2005WO2005082856A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005WO2005082853A1 Semicarbazide derivatives as kinase inhibitors
09/09/2005WO2005082367A1 Kinase inhibitors
09/09/2005WO2005081687A2 Human hinge core mimetibodies, compositions, methods and uses
09/09/2005WO2005058885A3 Piperidine derivatives and their use as glycine transporter inhibitors
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005046603A3 Pyridine compounds
09/09/2005WO2005044192A3 Triazole compounds and uses related thereto
09/09/2005WO2005032493A3 Amide compounds as ion channel ligands and uses thereof
09/09/2005WO2005030151A3 Compounds and compositions as protein kinase inhibitors
09/09/2005WO2005014584A8 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis
09/09/2005WO2005009373A3 Tyrosine kinase inhibitors
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2557489A1 Piperidine derivatives
09/09/2005CA2557398A1 Benzimidazolyl derivatives as kinase inhibitors
09/09/2005CA2557359A1 Semicarbazide derivatives as kinase inhibitors
09/09/2005CA2556830A1 Methods and compositions comprising non-peptide small molecules that solubilize beta amyloid peptide fiber
09/09/2005CA2556768A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005CA2556413A1 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
09/09/2005CA2555720A1 Isoquinoline derivatives
09/09/2005CA2554627A1 Immunosuppressant compounds and compositions
09/09/2005CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1)
09/08/2005US20050197377 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders
09/08/2005US20050197375 Use of benzimidazole analogs in the treatment of cell proliferation
09/08/2005US20050197364 Amide compounds as ion channel ligands and uses thereof
09/08/2005US20050197361 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/08/2005US20050197354 4-[[4-[(2,6-dichloro-phenyl)methyl]-6-[[2-(1-pyrrolidinyl)ethyl]amino]-2-pyrimidinyl]amino]benzonitrile; 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzamide, N1-oxide combined with another retrovirus inhibitor; viricides; treatment of AIDS
09/08/2005US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc.
09/08/2005US20050197351 Such as 4-{N-[4-(4-methylbenzenesulfonylamido)benzyl]acetamido}-3-phenyl-2-(piperidine-1-yl)-3,4-dihydroquinazoline; for therapy of angina pectoris, high blood pressure, myocardial disease, pain and epilepsy by blocking the T-type calcium channel
09/08/2005US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs
09/08/2005US20050197338 Substituted pyrazole urea compounds for the treatment of inflammation
09/08/2005US20050197337 Aminomethylpyrimidines as allosteric enhancers of the GABAB receptors
09/08/2005US20050197326 1,4-benzothiazin-3-ones that are optionally S-mono- or dioxygenated, quinoxazinones, quinolinones and benzapinones; peptide deformylase inhibitors, used for treating bacterial infections
09/08/2005US20050197325 Substituted spiro azabicyclics as modulators of chemokine receptor activity
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/08/2005DE102004009238A1 New aryl amide compounds are kinase inhibitors useful for the treatment and/or prophylaxis of e.g. tumors, psoriasis, rheumatoid arthritis, contact dermatitis, inflammations, endometriosis, scar and benign prostatic hyperplasia
09/07/2005EP1571147A2 Pyrazole analogs acting on cannabinoid receptors
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/07/2005EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists
09/07/2005EP1571144A1 Hydroxyalkylated cyclic diamine compound
09/07/2005EP1569941A1 Anthelmintic and insecticidal thiohene compositions
09/07/2005EP1569934A2 Cyclopropyl compounds as ccr5 antagonists
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569927A2 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
09/07/2005EP1569926A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569925A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569919A2 Non-nucleoside reverse transcriptase inhibitors
09/07/2005EP1569917A1 Pyrazine-based tubulin inhibitors
09/07/2005EP1569915A2 Spirocyclic ureas, compositions containing such compounds and methods of use
09/07/2005EP1569913A1 Compositions containing pyrimidine derivatives as inhibitors of cox-2
09/07/2005EP1569912A2 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
09/07/2005EP1569911A1 Indazole derivatives as crf antagonists
09/07/2005EP1569910A2 Pesticidal sulphonylaminopyrazoles
09/07/2005EP1569908A2 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
09/07/2005EP1569904A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
09/07/2005EP1569901A2 ARYL, ARYLOXY, AND ALKYLOXY SUBSTITUTED i 1H /i -INDOL-3-YL GLYOXYLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
09/07/2005EP1569647A2 Cyclohexyl compounds as ccr5 antagonists
09/07/2005EP1569644A2 Indolizine compounds
09/07/2005EP1569638A1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1569517A1 Pesticidal 5- (acylamino) pyrazole derivatives
09/07/2005EP1539702A4 Hydrophilic chemiluminescent acridinium labeling reagents
09/07/2005EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/07/2005EP1399434B1 Novel indole derivatives
09/07/2005EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
09/07/2005EP1349850B1 Sodium channel modulators derived from 2-piperidylimidazoles
09/07/2005EP1347957B1 Delta 1-pyrrolines used as pesticides
09/07/2005EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists